Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Supreme Cannabis Company Inc. (The) T.FIRE

The Supreme Cannabis Co Inc is a Canada-based company engaged in the production and sale of medical and recreational cannabis. Its portfolio includes products that address recreational, medical, and wellness consumers. Its brands include BlissCo, Truverra, 7ACRES, Sugarleaf, and Hiway.


TSX:FIRE - Post by User

Comment by Aurum1983on Feb 17, 2021 12:20pm
226 Views
Post# 32585220

RE:Supreme Cannabis: Stifel-GMP Raises Price Target To $0.55

RE:Supreme Cannabis: Stifel-GMP Raises Price Target To $0.55The TP will start increasing...we are only in the second inning.

Now is our chance to get in on the same footing as the big boys at .31 is the bottom. I just bought another 200000 shares at .31. We are not going to stick around here for long that much is a no brainer.


AwareInvestor - (2/17/2021 11:40:29 AM)
Supreme Cannabis: Stifel-GMP Raises Price Target To $0.55
Last week, The Supreme Cannabis Company announced its second quarter 2021 financial results. The company reported net revenues of C$18.3 million, an increase of 54% quarter over quarter, and EBITDA of C$3.6 million.

Supreme currently has four analysts covering the company with a weighted 12-month price target of C$0.41. This is up from the average before the results, which was C$0.21. One analyst has a buy rating, while the other three have hold ratings.
<< Previous
Bullboard Posts
Next >>